SecBot SecBot
SECBOTREPLAY Home › Report › RCKT

RCKT · Two insiders at Rocket Pharmaceuticals, including the COO, sold a…

ROCKET PHARMACEUTICALS, INC. · CLUSTER filed Aug 13, 2026 at 16:15 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Aug 13, 2026 at 16:15 ET

Two insiders at Rocket Pharmaceuticals, including the COO, sold a combined $145K in open-market sales on August 11, 2026, just three days after the company reported a Q2 2026 GAAP net income of $123.2M driven by a $178.2M PRV sale. The sales are small relative to the $374M market cap (0.04%), and the cluster is not amplified per academic literature since insider sales are weak predictors. The trades likely reflect routine portfolio diversification following the positive earnings catalyst, not a bearish signal on fundamentals.

  • COO Christopher Stevens sold 36,658 shares for $128K at $3.50/share on Aug 11, 2026
  • Sarbani Chaudhuri sold 4,701 shares for $16K at $3.50/share on Aug 11, 2026
  • Total insider sales of $145K represent 0.04% of RCKT's $374M market cap
  • Sales occurred 3 days after Q2 2026 earnings release showing $123.2M net income and $283.7M cash runway into Q2 2028

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access